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Introduction
Lung cancer is currently the leading cause of cancer-related death worldwide, accounting for approximately a third of all cancer diagnoses and death. The high mortality rate associated with lung cancer has prompted numerous exhaustive efforts to identify novel therapeutic targets and treatment modalities for this lethal disease [1] . Most lung cancer patients died of metastasis, especially lung adenocarcinoma, which often metastasizes when the primary tumor size is still quite small. The molecular mechanism underlying the early metastasis of lung adenocarcinoma has been instrumental in developing novel therapeutic strategies to target this aggressive metastatic disease. It is necessary to further investigate the molecular determinants of treatment resistance and to develop novel therapeutic strategies the heterogeneity and convergence of signaling pathways underlying lung adenocarcinoma [5, 6] , efforts are needed to improve a better understanding of the molecular origins and evolution of it in the future.
Previous studies in lung adenocarcinoma genome focused on mutations for targeted chemotherapy, recurrence of genetic mutations, genome-wide structure variants and as targeted chemotherapy for lung cancer treatment [7, 8] . In lung adenocarcinoma, frequently recurrent and loss-of-function mutations, or deletions in tumor suppressor have all characterized the special study describing whole-exome sequencing of 16 lung adenocarcinomas enumerated several mutated genes but did not identify genes undergoing positive selection for mutation in mutation signatures were correlated with smoking history [16] . Unfortunately, such recurrent cancer metastasis. Therefore, knowledge of additional genes altered in lung adenocarcinoma metastasis is needed to further guide diagnosis and treatment.
been found with the development of sequencing technique. The historically proven approach of understanding evolution is the comparative analysis of extant species, whose power was greatly increased by whole genome sequencing in recent years. The concept acquired genetic instability increases as a neoplasm progress, resulting in heterogeneity
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry evolutionary lineage trees, comparisons of somatic genomes from a single individual could shed light on somatic evolution in principle. In this regard, given the large number of genomic changes during tumor evolution, it may be possible to dissect the evolutionary history of a cancer by comparing its genome to clinically recognized precursor lesions.
In the current study, therefore, using next-generation sequencing of the whole exomes with frequent somatic alterations that has been reported in the previous studies of lung progression from normal tissue to primary tumor, and to metastatic tumor; and found conceptualization of lung adenocarcinoma origins and progression.
Materials and Methods

Patient and Sample Characteristics
specimens were grossly dissected and preserved immediately in liquid nitrogen. Each specimen of lung adenocarcinoma was segregated into six parts, that is, three primary adenocarcinomas and three metastatic
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Evolution analysis phylogenetic tree of relationships among the metastases and primary tumor. The length of black lines is proportional to the genetic distance between nodes.
with highly enriched annotation terms as found in the traditional enrichment analysis of the total gene list.
that the geometric mean was a relative score rather than an absolute p value, minus log transformation
Statistical Analyses
The hierarchical clustering was performed on the somatic mutations on gene level for each patient
Results
Exome sequence analysis of lung adenocarcinoma
We examined four primary lung adenocarcinoma and their chest wall metastasis nodules of the tumor and to reconstruct the path of the cancer metastasis, both primary tumor and data for each sample. Patients' clinical and histopathological information was presented in The somatic mutation genes found in the current study were compared with that about recurrent genes in lung adenocarcinoma, and the data quality was normal and passed others, we further explored the driver somatic genes in cancer clonal evolution, which may contribute to the cancer metastasis, and to focus on the recurrent genes.
Heterogeneity of the mutational landscape and branched evoluation within an individual cancer
separated samples of the primary and metastatic biopsies. The results showed that lung evolution, and we described this at the level of cancer genes and within individual patients.
To further elucidate the evolution of lung adenocarcinoma, we analyzed ancestral relationships and reconstructed a phylogenetic tree of every lung adenocarcinoma by evolutionary tree revealed branched evolutionary tumor growth in all intra-tumors with their special patterns. Mutations in a primary and a metastatic tumor tissue have nested development. In analysis for four patients, branch lengths are proportional to the number of non-synonymous mutations separating the branching points (cancer local specimen with indicated genes in the branch.
analysis to reconstruct the evolution path. It was shown that this metastasis onset event primary and the metastasis specimen may have experienced punctuated evolutional events.
the similar branching pattern with punctuated evolution characters between primary and metastasis.
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry of the recurrently mutated genes, which was occurred only in the metastatic tumors. It was functional enrichment analysis and found that most of the mutated genes function in the genes involve in functions like sensory perception of chemical stimulus, sensory perception, signaling pathway, and phosphatase activity.
Discussion
Whole exome sequencing and integrative analysis of genomic data provided the mutational landscape of tumors and new insights into cancer genome evolution, laying bare the interplay of somatic mutations, adaptation of clones to their environment and natural selection. Multiregional genetic analysis of four consecutive tumors provided evidence of intra-tumor heterogeneity in every lung adenocarcinoma, with spatially separated sequencing, most of them were heterogeneous and thus not detectable in every sequenced ching points. Potential driver mutations were acquired by the indicated.
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry region. In the metastasis lesions of every lung adenocarcinoma, it was also showed that high heterogeneity due to the different patterns of somatic mutations to drive cancer metastasis. Evolution is the result of natural selection, so is the progression of cancer. In this study, we updated the understanding of the dynamic evolution of the cancer genome in a lung adenocarcinoma. The implications for lung adenocarcinoma metastasis is counterintuitive that most of metastasis occur early after the primary tumor with punctuated mode in our of time with little or no change, separated by short periods of time of large dramatic changes.
Evolution includes gradual and punctuated evolution, the latter occurs where the increment of change is very large compared to that of time in discrete intervals. It looks like abrupt emergence of forms with little or no transitional stages, when in reality the evolution ubiquitous alterations in the trunk of the phylogenetic tree. Larger multiregional series will probably identify genes that can be targeted in the trunks of the phylogenetic tree for lung carcinoma. Intra-tumor heterogeneity within the primary tumor may account for little accumulation of mutations and time to grow and metastasis; that the metastatic tumor have early onset from the primary tumor, need little time to accumulate or process on genetic in these four patients; and that the primary and metastasis clonal evolution processed separately and extended the mutational accumulations to other primary and metastasis loci in each branch.
We have demonstrated the extent of the heterogeneity of lung adenocarcinoma genomes, have allowed inferences to be made about the forces that act on nascent cancer clones as they evolve, and have shown insights into the mutational processes that generate genetic our results with other large-scale analyses mutated genes. Every primary tumor and metastasis lesion has its special mutational gene considered as a biomarker of response to chemotherapy with cytidine analogues and genetic study has characterized genotypes in gemcitabine pathway genes have association with tumor cell survival and adaption in local tissue environment. 
